The study plans to evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
Laura Esserman, professor in the Department of Surgery and Radiology at the UCSF Helen Diller Comprehensive Cancer Center has always been an out-of-the-box thinker. Now, as she leads the Athena Breast Health Network, they are ready to launch the WISDOM (Women Informed to Screen Depending on Measures of Risk) study, which will evaluate the impact of a personalized approach to breast cancer screening over an annual mammogram.
"The essence of precision medicine is being able to tailor treatment to biology, patient preference and clinical performance," according to Esserman.
Read more here.